INtervention Study In overweiGHT Patients With COPD

a study on Chronic Obstructive Pulmonary Disease Obesity Weight Loss Life Style

Summary

for people ages 40 years and up (full criteria)
at San Francisco, California and other locations
study started
estimated completion:
Stephen Lazarus

Description

Summary

Symptoms of chronic obstructive pulmonary disease (COPD) and high body mass index (BMI) overlap. The investigators are trying to find out if a program proven to help people lose a modest amount of weight and increase their physical activity will improve COPD symptoms for those with a high BMI. The program uses a series of digital video discs (DVD) sessions focused on healthy eating and physical activity, and encourages participants to monitor their weight, diet, and physical activity for two years. For those who want to, they will be able to work with a health coach to help meet weight and activity goals. We hope that the program will lead to weight loss, better exercise tolerance, and less shortness of breath. To be in the study, participants will need to have COPD, high BMI, history of smoking, shortness of breath, and be at least 40 years old.

Keywords

Pulmonary Disease, Chronic Obstructive Obesity Weight Loss Life Style Overweight randomized controlled trial diet exercise chronic obstructive pulmonary disease lifestyle Lung Diseases Chronic Disease Lifestyle Intervention

Eligibility

You can join if…

Open to people ages 40 years and up

  • 40 years or older at time of eligibility screening;
  • Body mass index 25.0-44.9 kg/m2 (also see Figure 2);
  • Smoked more than 10 pack-years of cigarettes;
  • Shortness of breath;
  • COPD;
  • Able to participate fully in all study protocol/procedures including written informed consent process.

You CAN'T join if...

  • Inability to speak, read, or understand English;
  • Active weight loss interventions;
  • Expected weight loss because of alternate explanations, such as from illness;
  • Unable to ambulate to weight scale for weight measurement;
  • Safety and/or adherence concerns due to severe physical or mental health issues or life expectancy <24 months;
  • Pregnant, lactating, or planning to become pregnant during the study period;
  • Participation in other intervention studies.

Locations

  • Universtiy of California, San Francisco accepting new patients
    San Francisco California 94143 United States
  • University of California, Los Angeles accepting new patients
    Los Angeles California 90095 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Seattle Institute for Biomedical and Clinical Research
ID
NCT02634268
Lead Scientist
Stephen Lazarus
Study Type
Interventional
Last Updated
May 8, 2018